装着型サイボーグが未来を変える
Location: Japan, Ibaraki Prefecture, Tsukuba
Employees: 51-200
Founded date: 2004
Investors 2
Date | Name | Website |
- | Lead Capit... | leadcapita... |
- | J-Startup | j-startup.... |
Mentions in press and media 21
Date | Title | Description |
16.07.2024 | Okayama University “Okayama Living Lab” will be held with Cyberdyne, a venture company from the University of Tsukuba, to discuss business ideas using the world’s first wearable cyborg HAL. | National University Corporation Okayama University [Okayama University] “Okayama Living Lab” will be held with Cyberdyne, a venture company from the University of Tsukuba, to discuss business ideas using the world’s first wearable cyborg HA... |
30.06.2024 | Okayama University “Okayama Living Lab” Open Innovation Program (O2IP) 27th ~Business ideas for utilizing wearable cyborg HAL~ 7/10, Wednesday hybrid event | National University Corporation Okayama University [Okayama University] “Okayama Living Lab” Open Innovation Program (O2IP) 27th ~Business ideas for utilizing wearable cyborg HAL~ [7/10, Wednesday hybrid event] …… June 30, 2024 (Reiwa 6) Na... |
12.03.2024 | Global Rehabilitation Robotics Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors | Rehabilitation Robotics Market Report 2024 – Market Size, Trends, And Forecast 2024-2033 The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033 The rehabilitation robotics ma... |
19.01.2024 | Medical Note, which operates Japan’s largest medical information media for patients, enters into a strategic partnership with CYBERDYNE | Medical Note Co., Ltd. Medical Note, which operates Japan’s largest medical information media for patients, enters into a strategic partnership with CYBERDYNE Started disseminating information on progressive neurological and muscular intrac... |
29.06.2022 | Metcela Inc. Completes the Series C Financing of Total $14 Million | KANAGAWA, Japan (PRWEB) June 29, 2022 Metcela, a clinical-stage biotechnology company developing first-in-class autologous cell therapies targeting serious cardiovascular diseases, today announced the closing of a $14 million Series C round... |
22.12.2021 | CYBERDYNE : 【IR News】Establishment of a subsidiary in Malaysia | The Board of Directors of CYBERDYNE has resolved to establish a subsidiary in Malaysia at a meeting held on December 21, 2021, as follows. 1. Purpose of establishing the subsidiary CYBERDYNE announces to establish CYBERDYNE MALAYSIA (tentat... |
05.10.2021 | CYBERDYNE : 【IR News】Announce on the adoption by AMED Medical Engineering Innovation Promotion Project ~ enables real-time photoacoustic imaging of peripheral capillaries and oxygenation level distrib... | CYBERDYNE Inc. (Tsukuba, Ibaraki, Japan, President & CEO: Yoshiyuki Sankai, from now on referred to as "the Company") announces that the Japan Agency adopted the Company's proposal on Photoacoustic Imaging Technology for Medic... |
02.09.2021 | CYBERDYNE : 【News】Medical HAL Single Joint Type receives medical device approval from Australian regulator | 2021/9/2 Company: CYBERDYNE Inc. Name of Yoshiyuki Sankai, Representative: President and CEO Code: 7779 (Mothers Section of the Tokyo Stock Exchange) Contact: Shinji Uga, Director and CFO (Tel. +81-29-869-9981) 【News】Medical HAL Single Join... |
01.06.2021 | CYBERDYNE INC. CYBERDYNE : Announcement on the expansion of Shareholder Benefit Program and establishment of Shareholder Reference Scheme | CYBERDYNE Inc. (the 'Company') announces that the Meeting of the Board of Directors held today passed the resolution to expand the Shareholder Benefit Program and establish Shareholder Reference Scheme. Please refer to the details stated be... |
30.03.2021 | CYBERDYNE INC. CYBERDYNE : HAL Single Joint Type receives medical device approval from Thai FDA | 2021/3/30 Company: CYBERDYNE Inc. Name of Yoshiyuki Sankai, Representative: President and CEO 7779 (Mothers Section of the Tokyo Code: Stock Exchange) Contact: Shinji Uga, Director and CFO (Tel. +81-29-869-9981) HAL Single Joint Type receiv... |
Show more